Leon N. Warne

Bentley, WA 6002, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

The toxicology of orally administered Δ9-tetrahydrocannabinol in sheep.

The toxicology of orally administered Δ9-tetrahydrocannabinol in sheep.

Journal: Toxicology reports

Published: December 18, 2025

Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis.

Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis.

Journal: International journal of molecular sciences

Published: July 07, 2025

Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease.

Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 27, 2025

Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.

Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 09, 2025

Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations.

Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations.

Journal: Cells

Published: October 24, 2024

The Pharmacokinetics of Δ9-Tetrahydrocannabinol in Sheep.

The Pharmacokinetics of Δ9-Tetrahydrocannabinol in Sheep.

Journal: Animals : an open access journal from MDPI

Published: September 30, 2024

Chronic metabolic effects of novel gut-oriented small-molecule GPR119 agonists in diet-induced obese mice.

Chronic metabolic effects of novel gut-oriented small-molecule GPR119 agonists in diet-induced obese mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 04, 2024

Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: The QUEST Initiative 12-month follow-up observational study.

Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: The QUEST Initiative 12-month follow-up observational study.

Journal: PloS one

Published: May 09, 2024

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity.

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 23, 2024

G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 18, 2023

Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.

Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.

Journal: International journal of molecular sciences

Published: August 19, 2023

Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.

Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.

Journal: Current biology : CB

Published: June 20, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026